289 related articles for article (PubMed ID: 23262200)
1. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
Shin SH; Lee J; Lim KS; Rhim T; Lee SK; Kim YH; Lee KY
J Control Release; 2013 Feb; 166(1):38-45. PubMed ID: 23262200
[TBL] [Abstract][Full Text] [Related]
2. Injectable microsphere/hydrogel hybrid system containing heat shock protein as therapy in a murine myocardial infarction model.
Lee J; Cha MJ; Lim KS; Kim JK; Lee SK; Kim YH; Hwang KC; Lee KY
J Drug Target; 2013 Nov; 21(9):822-9. PubMed ID: 23952941
[TBL] [Abstract][Full Text] [Related]
3. Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction.
Lee J; Tan CY; Lee SK; Kim YH; Lee KY
J Control Release; 2009 Aug; 137(3):196-202. PubMed ID: 19374930
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
Shin SH; Lee J; Ahn DG; Lee KY
Pharm Res; 2013 Aug; 30(8):2157-65. PubMed ID: 23686375
[TBL] [Abstract][Full Text] [Related]
5. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ
J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169
[TBL] [Abstract][Full Text] [Related]
6. Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system.
Lee J; Bhang SH; Park H; Kim BS; Lee KY
Pharm Res; 2010 May; 27(5):767-74. PubMed ID: 20221675
[TBL] [Abstract][Full Text] [Related]
7. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
9. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.
Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD
Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157
[TBL] [Abstract][Full Text] [Related]
10. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.
Lee J; Oh YJ; Lee SK; Lee KY
J Control Release; 2010 Aug; 146(1):61-7. PubMed ID: 20553775
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
12. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
[TBL] [Abstract][Full Text] [Related]
13. Enzymatically cross-linked injectable alginate-g-pyrrole hydrogels for neovascularization.
DeVolder R; Antoniadou E; Kong H
J Control Release; 2013 Nov; 172(1):30-37. PubMed ID: 23886705
[TBL] [Abstract][Full Text] [Related]
14. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.
Patil SD; Papadmitrakopoulos F; Burgess DJ
J Control Release; 2007 Jan; 117(1):68-79. PubMed ID: 17169457
[TBL] [Abstract][Full Text] [Related]
15. Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system.
Lee J; Lee KY
Pharm Res; 2009 Jul; 26(7):1739-44. PubMed ID: 19384466
[TBL] [Abstract][Full Text] [Related]
16. Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach.
d'Angelo I; Oliviero O; Ungaro F; Quaglia F; Netti PA
Acta Biomater; 2013 Jul; 9(7):7389-98. PubMed ID: 23523534
[TBL] [Abstract][Full Text] [Related]
17. Neovascularization by Sustained Delivery of G-CSF, EPO and VEGF Using Dextran/PLGA Microspheres.
Liu CD; Tu XF; Chen F
Ann Vasc Surg; 2020 Apr; 64():328-338. PubMed ID: 31634610
[TBL] [Abstract][Full Text] [Related]
18. Tunable sequential drug delivery system based on chitosan/hyaluronic acid hydrogels and PLGA microspheres for management of non-healing infected wounds.
Huang J; Ren J; Chen G; Li Z; Liu Y; Wang G; Wu X
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():213-222. PubMed ID: 29752091
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis.
Silva EA; Mooney DJ
J Thromb Haemost; 2007 Mar; 5(3):590-8. PubMed ID: 17229044
[TBL] [Abstract][Full Text] [Related]
20. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.
Zhong Y; Zhang L; Ding AG; Shenderova A; Zhu G; Pei P; Chen RR; Mallery SR; Mooney DJ; Schwendeman SP
J Control Release; 2007 Oct; 122(3):331-7. PubMed ID: 17706831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
